BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22134968)

  • 1. How clinical and research failures lead to suboptimal prescribing: the example of chronic gout.
    Lipworth W; Kerridge I; Brett J; Day R
    BMJ; 2011 Dec; 343():d7459. PubMed ID: 22134968
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment failure gout: failure to treat?
    Perry ME; Madhok R
    Rheumatology (Oxford); 2010 Dec; 49(12):2233-4. PubMed ID: 20463191
    [No Abstract]   [Full Text] [Related]  

  • 3. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
    Stuart RA; Gow PJ; Bellamy N; Campbell J; Grigor R
    N Z Med J; 1991 Mar; 104(908):115-7. PubMed ID: 2011292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of allopurinol in the Australian community.
    Chung Y; Lu CY; Graham GG; Mant A; Day RO
    Intern Med J; 2008 Jun; 38(6):388-95. PubMed ID: 18422564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine prescribing in patients with gout.
    Dalbeth N; Gow P;
    N Z Med J; 2011 Jul; 124(1339):107-8. PubMed ID: 21952339
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 9. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB
    Harv Mens Health Watch; 2010 Jan; 14(6):7-8. PubMed ID: 20464796
    [No Abstract]   [Full Text] [Related]  

  • 10. Colchicine prescribing and safety monitoring in patients with gout.
    Ly J; Gow P; Dalbeth N
    N Z Med J; 2007 Nov; 120(1265):U2808. PubMed ID: 18264188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings.
    Pandya BJ; Riedel AA; Swindle JP; Becker LK; Hariri A; Dabbous O; Krishnan E
    Curr Med Res Opin; 2011 Apr; 27(4):737-44. PubMed ID: 21271794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 13. A survey on the current evaluation and treatment of gout in Buenos Aires, Argentina.
    Fara N; Vázquez Mellado J; Sequeira G; Kerzberg E
    Reumatol Clin; 2012; 8(6):306-9. PubMed ID: 22854175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of colchicine toxicity in patients with gout.
    Dalbeth N; Gow P
    N Z Med J; 2007 Apr; 120(1252):U2503. PubMed ID: 17460750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hyperuricemia and gout based on the guideline for the management of hyperuricemia and gout].
    Taniguchi A
    Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):330-4. PubMed ID: 21139283
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of indicators assessing the quality of drug prescribing for asthma.
    Veninga CC; Denig P; Pont LG; Haaijer-Ruskamp FM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):143-61. PubMed ID: 11324741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N; Stamp L
    Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol--dose according to effect, not renal function.
    Bryant L
    J Prim Health Care; 2011 Dec; 3(4):323. PubMed ID: 22235497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.